Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk.

Gaetano IsolaAngela AlibrandiMonica CurròMarco MatareseSergio RiccaGiovanni MatareseRiccardo IentileThomas Kocher

Published in: Journal of periodontology (2020)

Patients with CHD and CP + CHD presented higher levels of salivary and serum ADMA compared to healthy subjects and CP patients. hs-CRP was a significant predictor of increased salivary and serum ADMA levels.

Keyphrases

cardiovascular disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
metabolic syndrome